Cargando…

Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy

As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and inte...

Descripción completa

Detalles Bibliográficos
Autores principales: von Schoen-Angerer, Tido, Manchanda, Raj Kumar, Lloyd, Iva, Wardle, Jon, Szöke, Janka, Benevides, Iracema, Martinez, Natalia Sofia Aldana, Tolo, Festus, Nicolai, Ton, Skaling-Klopstock, Cristal, Parker, Tabatha, Suswardany, Dwi Linna, van Haselen, Robbert, Liu, Jianping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693890/
http://dx.doi.org/10.1136/bmjgh-2023-013150
_version_ 1785153259601657856
author von Schoen-Angerer, Tido
Manchanda, Raj Kumar
Lloyd, Iva
Wardle, Jon
Szöke, Janka
Benevides, Iracema
Martinez, Natalia Sofia Aldana
Tolo, Festus
Nicolai, Ton
Skaling-Klopstock, Cristal
Parker, Tabatha
Suswardany, Dwi Linna
van Haselen, Robbert
Liu, Jianping
author_facet von Schoen-Angerer, Tido
Manchanda, Raj Kumar
Lloyd, Iva
Wardle, Jon
Szöke, Janka
Benevides, Iracema
Martinez, Natalia Sofia Aldana
Tolo, Festus
Nicolai, Ton
Skaling-Klopstock, Cristal
Parker, Tabatha
Suswardany, Dwi Linna
van Haselen, Robbert
Liu, Jianping
author_sort von Schoen-Angerer, Tido
collection PubMed
description As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and integrative healthcare (TCIH) to address specific diseases as a dimension absent in the current strategy. Our analysis concludes on five areas. First, TCIH research is increasing but is not commensurate with TCIH use. TCIH research needs prioritisation and increased funding in national research policies and programmes. Second, WHO guidance for training and practice provides useful minimum standards but regulation of TCIH practitioners also need to reflect the different nature of formal and informal practices. Third, there has been progress in the regulation of herbal medicines but TCIH products of other origin still need addressing. A risk-based regulatory approach for the full-range of TCIH products seems appropriate and WHO should provide guidance in this regard. Fourth, the potential of TCIH to help address specific diseases is often overlooked. The development of disease strategies would benefit from considering the evidence and inclusion of TCIH practices, as appropriate. Fifth, inclusion of TCIH in national health policies differs between countries, with some integrating TCIH practices and others seeking to restrict them. We encourage a positive framework in all countries that enshrines the role of TCIH in the achievement of universal health coverage. Finally, we encourage seeking the input of stakeholders in the development of the new WHO Traditional Medicine Strategy.
format Online
Article
Text
id pubmed-10693890
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106938902023-12-04 Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy von Schoen-Angerer, Tido Manchanda, Raj Kumar Lloyd, Iva Wardle, Jon Szöke, Janka Benevides, Iracema Martinez, Natalia Sofia Aldana Tolo, Festus Nicolai, Ton Skaling-Klopstock, Cristal Parker, Tabatha Suswardany, Dwi Linna van Haselen, Robbert Liu, Jianping BMJ Glob Health Analysis As the ‘WHO Traditional Medicine Strategy: 2014–2023’ is entering its final phase, reflection is warranted on progress and the focus for a new strategy. We used WHO documentation to analyse progress across the objectives of the current strategy, adding the role of traditional, complementary and integrative healthcare (TCIH) to address specific diseases as a dimension absent in the current strategy. Our analysis concludes on five areas. First, TCIH research is increasing but is not commensurate with TCIH use. TCIH research needs prioritisation and increased funding in national research policies and programmes. Second, WHO guidance for training and practice provides useful minimum standards but regulation of TCIH practitioners also need to reflect the different nature of formal and informal practices. Third, there has been progress in the regulation of herbal medicines but TCIH products of other origin still need addressing. A risk-based regulatory approach for the full-range of TCIH products seems appropriate and WHO should provide guidance in this regard. Fourth, the potential of TCIH to help address specific diseases is often overlooked. The development of disease strategies would benefit from considering the evidence and inclusion of TCIH practices, as appropriate. Fifth, inclusion of TCIH in national health policies differs between countries, with some integrating TCIH practices and others seeking to restrict them. We encourage a positive framework in all countries that enshrines the role of TCIH in the achievement of universal health coverage. Finally, we encourage seeking the input of stakeholders in the development of the new WHO Traditional Medicine Strategy. BMJ Publishing Group 2023-12-02 /pmc/articles/PMC10693890/ http://dx.doi.org/10.1136/bmjgh-2023-013150 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Analysis
von Schoen-Angerer, Tido
Manchanda, Raj Kumar
Lloyd, Iva
Wardle, Jon
Szöke, Janka
Benevides, Iracema
Martinez, Natalia Sofia Aldana
Tolo, Festus
Nicolai, Ton
Skaling-Klopstock, Cristal
Parker, Tabatha
Suswardany, Dwi Linna
van Haselen, Robbert
Liu, Jianping
Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
title Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
title_full Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
title_fullStr Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
title_full_unstemmed Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
title_short Traditional, complementary and integrative healthcare: global stakeholder perspective on WHO’s current and future strategy
title_sort traditional, complementary and integrative healthcare: global stakeholder perspective on who’s current and future strategy
topic Analysis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693890/
http://dx.doi.org/10.1136/bmjgh-2023-013150
work_keys_str_mv AT vonschoenangerertido traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT manchandarajkumar traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT lloydiva traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT wardlejon traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT szokejanka traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT benevidesiracema traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT martineznataliasofiaaldana traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT tolofestus traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT nicolaiton traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT skalingklopstockcristal traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT parkertabatha traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT suswardanydwilinna traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT vanhaselenrobbert traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy
AT liujianping traditionalcomplementaryandintegrativehealthcareglobalstakeholderperspectiveonwhoscurrentandfuturestrategy